The results of sensitivity, specificity, negative predictive value (NPV), and positive predictive value (PPV) of the modified test were 100 %, 96.7 %, 100 %, and 96.7 %, respectively
Other side effects in these trials were nausea in up to 60% of patients, dysesthesia in 8.8 to 20.9%, and heart rhythm changes in 6% versus 3% for placebo
By contrast, no significant differences were observed in response to GEP12 at 5 nmol/kg/day (food intake: mean difference 20.0 kcal/day, 95% CI 41.4 to 1.5 kcal/day, p = 0.067
4 to 6 Years: The average diagnostic delay for inflammatory bowel conditions when early biomarker testing is skipped
Step two: prescription and pharmacy fulfillment Once approved, GobyMeds sends your prescription to their pharmacy partner